Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline-Reference-Cited by-同舟云学术

Bone Health and Bone-Targeted Therapies for Prostate Cancer: American Society of Clinical Oncology Endorsement Summary of a Cancer Care Ontario Guideline

Published:2020-07 Issue:7 Volume:16 Page:389-393
ISSN:2688-1527
Container-title:JCO Oncology Practice
language:en
Short-container-title:JCO Oncology Practice

Author:

Saylor Philip J.¹,Rumble R. Bryan²,Michalski Jeff M.³

Affiliation:

1. Massachusetts General Hospital, Boston, MA

2. American Society of Clinical Oncology, Alexandria, VA

3. Washington University School of Medicine, St. Louis, MO

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Oncology (nursing),Health Policy,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.19.00778

Reference18 articles.

1. Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer

2. Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline

3. NCCN Task Force Report: Bone Health in Cancer Care

4. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management;American Society of Clinical Oncology Educational Book;2024-06

2. Poor Bone Mineral Density Is Associated With Increased Risk of Urological Bone Metastases;Urology;2024-05

3. Real-World Evaluation of Primary Versus Secondary Prevention of Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer;The Oncologist;2024-03-25

4. Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects;Supportive Care in Cancer;2024-03

5. Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System;JCO Oncology Practice;2024-01